Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fernandez-Egea

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Acta Psychiatrica Scandinavica|July 22, 2014
The thrifty psychiatric phenotypeC Garcia-Rizo, E Fernandez-Egea, M Bernardo, et al.
Molecular Psychiatry|October 24, 2009
Stem cell signaling in newly diagnosed, antipsychotic-naive subjects with nonaffective psychosisE Fernandez-Egea, A Bruna, C Garcia-Rizo, et al.
Molecular Psychiatry|August 25, 2023
Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophreniaY Saleh, I Jarratt-Barnham, P Petitet, et al.
Molecular Psychiatry|April 15, 2015
Valence-dependent influence of serotonin depletion on model-based choice strategyY Worbe, S Palminteri, G Savulich, et al.
Acta Psychiatrica Scandinavica|September 13, 2013
"Is bipolar disorder an endocrine condition?" Glucose abnormalities in bipolar disorderC Garcia-Rizo, B Kirkpatrick, E Fernandez-Egea, et al.
Comprehensive Psychiatry|July 7, 2014
Spanish adaptation and validation of the Brief Negative Symptoms ScaleA Mané, C García-Rizo, M P Garcia-Portilla, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 4, 2017
Metabolic syndrome or glucose challenge in first episode of psychosis?C Garcia-Rizo, E Fernandez-Egea, C Oliveira, et al.
Schizophrenia Research|April 17, 2017
Inverse association between negative symptoms and body mass index in chronic schizophreniaG Mezquida, G Savulich, C Garcia-Rizo, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 19, 2020
Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-naïve first-episode psychosisA Toll, D Bergé, K Burling, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 27, 2016
Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disordersG Mezquida, R Penadés, B Cabrera, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Acta Psychiatrica Scandinavica|July 22, 2014
The thrifty psychiatric phenotypeC Garcia-Rizo, E Fernandez-Egea, M Bernardo, et al.
Molecular Psychiatry|October 24, 2009
Stem cell signaling in newly diagnosed, antipsychotic-naive subjects with nonaffective psychosisE Fernandez-Egea, A Bruna, C Garcia-Rizo, et al.
Molecular Psychiatry|August 25, 2023
Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophreniaY Saleh, I Jarratt-Barnham, P Petitet, et al.
Molecular Psychiatry|April 15, 2015
Valence-dependent influence of serotonin depletion on model-based choice strategyY Worbe, S Palminteri, G Savulich, et al.
Acta Psychiatrica Scandinavica|September 13, 2013
"Is bipolar disorder an endocrine condition?" Glucose abnormalities in bipolar disorderC Garcia-Rizo, B Kirkpatrick, E Fernandez-Egea, et al.
Comprehensive Psychiatry|July 7, 2014
Spanish adaptation and validation of the Brief Negative Symptoms ScaleA Mané, C García-Rizo, M P Garcia-Portilla, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 4, 2017
Metabolic syndrome or glucose challenge in first episode of psychosis?C Garcia-Rizo, E Fernandez-Egea, C Oliveira, et al.
Schizophrenia Research|April 17, 2017
Inverse association between negative symptoms and body mass index in chronic schizophreniaG Mezquida, G Savulich, C Garcia-Rizo, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 19, 2020
Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-naïve first-episode psychosisA Toll, D Bergé, K Burling, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 27, 2016
Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disordersG Mezquida, R Penadés, B Cabrera, et al.
Pageof 2